Endocrinology/Metabolics Market Research Reports & Industry Analysis
Endocrinologists are specially trained doctors in treating hormone imbalances and problems. Most endocrine disorders are chronic and need continuous treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid and hyperparathyroid disorders, and osteoporosis. Some less common but serious endocrine disorders include, but are not limited to: Addison’s disease, Cushing’s syndrome, pheochromocytoma, and disorders of sexual development.
In the United States, the most common endocrine disease is diabetes mellitus. Diabetes mellitus is a group of diseases categorized by a deficiency in insulin production or the ability of the body to use it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes has made endocrinology/metabolics one of the most in-demand and important medical sects.
Endocrinology/Metabolics Industry Research & Market Reports
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Global Recession Risk Impact
... Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with ... Read More
-
Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028
... clinical chemistry analyzers market size is projected to reach USD 16.5 billion by 2028 from USD 13.0 billion in 2023, at a CAGR of 4.9% during the forecast period. The clinical chemistry analyzers market is ... Read More
-
UAE Genetic Testing Market By Type (Carrier Testing, Diagnostic Testing, New-born Screening, Predictive & Presymptomatic Testing, Prenatal Testing, Others), By Disease (Sickle Cell Anemia, Thalassemia, Huntington's Disease, Cancer, Others), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027
... Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027 UAE genetic testing market is anticipated to register growth with an impressive CAGR in ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User ... Read More
-
Global Cord Blood Banking Market By Service (Sample Preservation & Storage, Sample Analysis, Sample Processing, Sample Collection & Transportation), By Component (Cord Blood v/s Cord Tissue), By Application (Cancer Disease, Diabetes, Blood Disease, Immune Disorders, Metabolic Disorders, Others), By Sector (Public Cord Blood Banks v/s Private cord Blood Banks), By Company, and By Region, Competition Forecast and Opportunities, 2027
... Metabolic Disorders, Others), By Sector (Public Cord Blood Banks v/s Private cord Blood Banks), By Company, and By Region, Competition Forecast and Opportunities, 2027 The global cord blood banking market is anticipated to observe impressive ... Read More
-
2022 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (E00-E89) Global Market Size & Growth Report with Updated Forecasts
... are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell endocrine, nutritional and metabolic diseases, and immunity disorders (e00-e89) combined with country and ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Small molecule drugs have represented some of the crucial blockbusters in the ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $10.7 and in terms of global GDP, the market was 0.09%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.6% preceded and followed ... Read More
-
2022 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (E00-E89) Global Market Size & Growth Report with COVID-19 Impact
... Growth Report covers market size, revenue, growth, and share across 4 global regions, 22 subregions, and 216 countries. Figures are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth ... Read More
-
India Thyroid Function Test Market, By Test Type (TSH, T3, T4, FT3, FT4, Others), By End User (Clinics, Research Organizations, Diagnostic Laboratories, Hospitals) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism and hyperthyroidism. Thyroid can be caused by iodine deficiency and autoimmune disease. Iodine deficiency is a major factor ... Read More
-
The 2023-2028 World Outlook for Hormone Replacement Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer, Troponin I}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share ... Read More
-
2022 Global: Hormones, Prostaglandins, Thromboxanes And Leukotrienes, Natural Or Reproduced By Synthesis Products-Manufacturing Forecast (2028) report
... market size, projected growth/decline and regional data for the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size ... Read More
-
Metabolic Syndrome - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metabolic Syndrome Understanding The DelveInsight Metabolic Syndrome ... Read More
-
Neuroendocrine Tumors (NETs) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Neuroendocrine Tumors (NETs) Understanding The ... Read More
Research Assistance
